Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5959 | 1551 | 42.7 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
578 | 3 | CHEMOKINES//CXCR4//MACROPHAGE MIGRATION INHIBITORY FACTOR | 16225 |
3435 | 2 | MACROPHAGE MIGRATION INHIBITORY FACTOR//MIF//MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | 1551 |
5959 | 1 | MACROPHAGE MIGRATION INHIBITORY FACTOR//MIF//MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | 1551 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MACROPHAGE MIGRATION INHIBITORY FACTOR | authKW | 6017467 | 26% | 77% | 396 |
2 | MIF | authKW | 3168202 | 16% | 65% | 246 |
3 | MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | authKW | 1428583 | 5% | 92% | 79 |
4 | CD74 | authKW | 526590 | 3% | 50% | 53 |
5 | MIGRATION INHIBITORY FACTOR | authKW | 376248 | 2% | 66% | 29 |
6 | TAUTOMERASE | authKW | 229063 | 1% | 73% | 16 |
7 | D DOPACHROME TAUTOMERASE | authKW | 202479 | 1% | 86% | 12 |
8 | TAUTOMERASE ACTIVITY | authKW | 139986 | 1% | 89% | 8 |
9 | ISO 1 | authKW | 125986 | 1% | 80% | 8 |
10 | MIF GENE | authKW | 118115 | 0% | 100% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 3424 | 24% | 0% | 366 |
2 | Cell Biology | 1349 | 17% | 0% | 258 |
3 | Biochemistry & Molecular Biology | 830 | 23% | 0% | 352 |
4 | Rheumatology | 647 | 4% | 0% | 62 |
5 | Medicine, Research & Experimental | 482 | 8% | 0% | 119 |
6 | Oncology | 368 | 10% | 0% | 155 |
7 | Endocrinology & Metabolism | 159 | 5% | 0% | 80 |
8 | Peripheral Vascular Diseases | 114 | 3% | 0% | 51 |
9 | Pathology | 93 | 3% | 0% | 45 |
10 | Critical Care Medicine | 85 | 2% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM MOL CELL BIOL | 84137 | 4% | 7% | 64 |
2 | BAXTER BIOMED | 59057 | 0% | 100% | 3 |
3 | CHAIR INTER IAL ENGN | 54678 | 0% | 56% | 5 |
4 | IMMUNOENDOCRINOL REPROD PHYSIOL | 54678 | 0% | 56% | 5 |
5 | ANLYAN | 52477 | 1% | 22% | 12 |
6 | MOL NEUROBIOL FUNCT NEUROPROTE | 44292 | 0% | 75% | 3 |
7 | INFLAMMATORY DIS | 39638 | 2% | 6% | 33 |
8 | CYTOKINE AUTOIMMUN UNIT | 39372 | 0% | 100% | 2 |
9 | JR GRP TUMOUR PROG S IMMUNE ESC E | 39372 | 0% | 100% | 2 |
10 | NEUROL UHS 46 | 39372 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR MEDICINE | 6691 | 1% | 1% | 23 |
2 | CYTOKINE | 6049 | 2% | 1% | 37 |
3 | JOURNAL OF IMMUNOLOGY | 842 | 3% | 0% | 50 |
4 | ARTHRITIS AND RHEUMATISM | 810 | 1% | 0% | 21 |
5 | DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY | 772 | 1% | 0% | 12 |
6 | MEDIATORS OF INFLAMMATION | 753 | 1% | 0% | 11 |
7 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 681 | 1% | 0% | 14 |
8 | GENES AND IMMUNITY | 677 | 0% | 1% | 7 |
9 | FASEB JOURNAL | 568 | 1% | 0% | 17 |
10 | FRONTIERS IN IMMUNOLOGY | 419 | 1% | 0% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MACROPHAGE MIGRATION INHIBITORY FACTOR | 6017467 | 26% | 77% | 396 | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR |
2 | MIF | 3168202 | 16% | 65% | 246 | Search MIF | Search MIF |
3 | MACROPHAGE MIGRATION INHIBITORY FACTOR MIF | 1428583 | 5% | 92% | 79 | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR+MIF | Search MACROPHAGE+MIGRATION+INHIBITORY+FACTOR+MIF |
4 | CD74 | 526590 | 3% | 50% | 53 | Search CD74 | Search CD74 |
5 | MIGRATION INHIBITORY FACTOR | 376248 | 2% | 66% | 29 | Search MIGRATION+INHIBITORY+FACTOR | Search MIGRATION+INHIBITORY+FACTOR |
6 | TAUTOMERASE | 229063 | 1% | 73% | 16 | Search TAUTOMERASE | Search TAUTOMERASE |
7 | D DOPACHROME TAUTOMERASE | 202479 | 1% | 86% | 12 | Search D+DOPACHROME+TAUTOMERASE | Search D+DOPACHROME+TAUTOMERASE |
8 | TAUTOMERASE ACTIVITY | 139986 | 1% | 89% | 8 | Search TAUTOMERASE+ACTIVITY | Search TAUTOMERASE+ACTIVITY |
9 | ISO 1 | 125986 | 1% | 80% | 8 | Search ISO+1 | Search ISO+1 |
10 | MIF GENE | 118115 | 0% | 100% | 6 | Search MIF+GENE | Search MIF+GENE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CALANDRA, T , ROGER, T , (2003) MACROPHAGE MIGRATION INHIBITORY FACTOR: A REGULATOR OF INNATE IMMUNITY.NATURE REVIEWS IMMUNOLOGY. VOL. 3. ISSUE 10. P. 791-800 | 98 | 88% | 738 |
2 | O'REILLY, C , DOROUDIAN, M , MAWHINNEY, L , DONNELLY, SC , (2016) TARGETING MIF IN CANCER: THERAPEUTIC STRATEGIES, CURRENT DEVELOPMENTS, AND FUTURE OPPORTUNITIES.MEDICINAL RESEARCH REVIEWS. VOL. 36. ISSUE 3. P. 440 -460 | 96 | 90% | 2 |
3 | MERK, M , MITCHELL, RA , ENDRES, S , BUCALA, R , (2012) D-DOPACHROME TAUTOMERASE (D-DT OR MIF-2): DOUBLING THE MIF CYTOKINE FAMILY.CYTOKINE. VOL. 59. ISSUE 1. P. 10-17 | 103 | 94% | 23 |
4 | BLOOM, J , SUN, S , AL-ABED, Y , (2016) MIF, A CONTROVERSIAL CYTOKINE: A REVIEW OF STRUCTURAL FEATURES, CHALLENGES, AND OPPORTUNITIES FOR DRUG DEVELOPMENT.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 20. ISSUE 12. P. 1463 -1475 | 115 | 83% | 0 |
5 | AL-ABED, Y , VANPATTEN, S , (2011) MIF AS A DISEASE TARGET: ISO-I AS A PROOF-OF-CONCEPT THERAPEUTIC.FUTURE MEDICINAL CHEMISTRY. VOL. 3. ISSUE 1. P. 45 -63 | 123 | 76% | 29 |
6 | SANCHEZ-NINO, MD , SANZ, AB , RUIZ-ANDRES, O , POVEDA, J , IZQUIERDO, MC , SELGAS, R , EGIDO, J , ORTIZ, A , (2013) MIF, CD74 AND OTHER PARTNERS IN KIDNEY DISEASE: TALES OF A PROMISCUOUS COUPLE.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 24. ISSUE 1. P. 23-40 | 140 | 63% | 20 |
7 | GARAI, J , LORAND, T , (2009) MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) TAUTOMERASE INHIBITORS AS POTENTIAL NOVEL ANTI-INFLAMMATORY AGENTS: CURRENT DEVELOPMENTS.CURRENT MEDICINAL CHEMISTRY. VOL. 16. ISSUE 9. P. 1091-1114 | 124 | 76% | 29 |
8 | SAULER, M , BUCALA, R , LEE, PJ , (2015) ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN AGE-RELATED LUNG DISEASE.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY. VOL. 309. ISSUE 1. P. L1 -L10 | 111 | 74% | 2 |
9 | GORDON-WEEKS, AN , LIM, SY , YUZHALIN, AE , JONES, K , MUSCHEL, R , (2015) MACROPHAGE MIGRATION INHIBITORY FACTOR: A KEY CYTOKINE AND THERAPEUTIC TARGET IN COLON CANCER.CYTOKINE & GROWTH FACTOR REVIEWS. VOL. 26. ISSUE 4. P. 451 -461 | 99 | 76% | 3 |
10 | SPARKES, A , DE BAETSELIER, P , ROELANTS, K , DE TREZ, C , MAGEZ, S , VAN GINDERACHTER, JA , RAES, G , BUCALA, R , STIJLEMANS, B , (2017) THE NON-MAMMALIAN MIF SUPERFAMILY.IMMUNOBIOLOGY. VOL. 222. ISSUE 3. P. 473 -482 | 85 | 89% | 0 |
Classes with closest relation at Level 1 |